Ray Camphausen, PHD

Dr. Ray Camphausen has more than 30 year of industrial experience in the discovery, research, and early development of biotechnology and pharmaceutical candidates. Prior to joining Wayland Biotherapeutics, Dr. Camphausen served as Associate Vice President, Research Fellow, and Director for 15 years at Bristol Myers-Squibb and Adnexus Therapeutics, a biotech company acquired by BMS in 2007. His focus at BMS/Adnexus was on the discovery and protein engineering of a variety of therapeutic candidates, including antibodies, alternative scaffold proteins, and other biologics in the areas of cancer, inflammation, and cardiovascular disease. In 2002, Dr. Camphausen served as Vice President, Research and Discovery at Thios Pharmaceutics, a biotech company focused on the discovery and development of small molecule and protein inhibitors in the general area of carbohydrate and protein sulfation. From 1987 to 2002, he was a research scientist and rose to Associate Director at Genetics Institute.